These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 19386911

  • 1. Cross-seeding fibrillation of Q/N-rich proteins offers new pathomechanism of polyglutamine diseases.
    Furukawa Y, Kaneko K, Matsumoto G, Kurosawa M, Nukina N.
    J Neurosci; 2009 Apr 22; 29(16):5153-62. PubMed ID: 19386911
    [Abstract] [Full Text] [Related]

  • 2. RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells.
    Doi H, Okamura K, Bauer PO, Furukawa Y, Shimizu H, Kurosawa M, Machida Y, Miyazaki H, Mitsui K, Kuroiwa Y, Nukina N.
    J Biol Chem; 2008 Mar 07; 283(10):6489-500. PubMed ID: 18167354
    [Abstract] [Full Text] [Related]

  • 3. Calmodulin regulates transglutaminase 2 cross-linking of huntingtin.
    Zainelli GM, Ross CA, Troncoso JC, Fitzgerald JK, Muma NA.
    J Neurosci; 2004 Feb 25; 24(8):1954-61. PubMed ID: 14985437
    [Abstract] [Full Text] [Related]

  • 4. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
    Dong X, Zong S, Witting A, Lindenberg KS, Kochanek S, Huang B.
    J Gene Med; 2012 Jul 25; 14(7):468-81. PubMed ID: 22700462
    [Abstract] [Full Text] [Related]

  • 5. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
    Huang CC, Faber PW, Persichetti F, Mittal V, Vonsattel JP, MacDonald ME, Gusella JF.
    Somat Cell Mol Genet; 1998 Jul 25; 24(4):217-33. PubMed ID: 10410676
    [Abstract] [Full Text] [Related]

  • 6. A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure.
    Poirier MA, Jiang H, Ross CA.
    Hum Mol Genet; 2005 Mar 15; 14(6):765-74. PubMed ID: 15689354
    [Abstract] [Full Text] [Related]

  • 7. Selection of behaviors and segmental coordination during larval locomotion is disrupted by nuclear polyglutamine inclusions in a new Drosophila Huntington's disease-like model.
    Nishimura Y, Yalgin C, Akimoto S, Doumanis J, Sasajima R, Nukina N, Miyakawa H, Moore AW, Morimoto T.
    J Neurogenet; 2010 Dec 15; 24(4):194-206. PubMed ID: 21087194
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions.
    Davranche A, Aviolat H, Zeder-Lutz G, Busso D, Altschuh D, Trottier Y, Klein FA.
    Hum Mol Genet; 2011 Jul 15; 20(14):2795-806. PubMed ID: 21518730
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice.
    Zheng S, Clabough EB, Sarkar S, Futter M, Rubinsztein DC, Zeitlin SO.
    PLoS Genet; 2010 Feb 05; 6(2):e1000838. PubMed ID: 20140187
    [Abstract] [Full Text] [Related]

  • 15. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H, Li Q, Graham RK, Slow E, Hayden MR, Bezprozvanny I.
    Neurobiol Dis; 2008 Jul 05; 31(1):80-8. PubMed ID: 18502655
    [Abstract] [Full Text] [Related]

  • 16. Effects of overexpression of huntingtin proteins on mitochondrial integrity.
    Wang H, Lim PJ, Karbowski M, Monteiro MJ.
    Hum Mol Genet; 2009 Feb 15; 18(4):737-52. PubMed ID: 19039036
    [Abstract] [Full Text] [Related]

  • 17. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.
    Omi K, Hachiya NS, Tanaka M, Tokunaga K, Kaneko K.
    Neurosci Lett; 2008 Jan 24; 431(1):45-50. PubMed ID: 18078716
    [Abstract] [Full Text] [Related]

  • 18. Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice.
    Yu ZX, Li SH, Nguyen HP, Li XJ.
    Hum Mol Genet; 2002 Apr 15; 11(8):905-14. PubMed ID: 11971872
    [Abstract] [Full Text] [Related]

  • 19. Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA.
    Wang YL, Liu W, Wada E, Murata M, Wada K, Kanazawa I.
    Neurosci Res; 2005 Nov 15; 53(3):241-9. PubMed ID: 16095740
    [Abstract] [Full Text] [Related]

  • 20. The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis.
    Holbert S, Denghien I, Kiechle T, Rosenblatt A, Wellington C, Hayden MR, Margolis RL, Ross CA, Dausset J, Ferrante RJ, Néri C.
    Proc Natl Acad Sci U S A; 2001 Feb 13; 98(4):1811-6. PubMed ID: 11172033
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.